PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutics Dept., Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: yasmin.abozeid@pharm.helwan.edu.eg.\', \'Pharmaceutical Chemistry Dept., Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt, Cairo 12311, Egypt. Electronic address: nasser.saad@fue.edu.eg.\', \'Cellular and Molecular Immunology Research Centre, London Metropolitan University, 166-220 Holloway Road, London, N7 8DB, UK; National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG UK. Electronic address: g.mclean@londonmet.ac.uk.\', \'Biochemistry Dept., Faculty of Pharmacy, Ain shams University, Cairo, 11566, Egypt. Electronic address: nadia_hamdy@pharma.asu.edu.eg.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0928-0987(20)30254-210.1016/j.ejps.2020.105465
?:doi
?:hasPublicationType
?:journal
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
is ?:pmid of
?:pmid
?:pmid
  • 32668312
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32668312>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32668312>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all